Agilent Technologies, Inc. (NYSE:A) Shares Sold by Logan Capital Management Inc.

Logan Capital Management Inc. decreased its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 7.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 103,732 shares of the medical research company's stock after selling 8,690 shares during the quarter. Logan Capital Management Inc.'s holdings in Agilent Technologies were worth $13,935,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. boosted its holdings in Agilent Technologies by 2.5% in the fourth quarter. Harbor Capital Advisors Inc. now owns 5,888 shares of the medical research company's stock valued at $791,000 after purchasing an additional 143 shares in the last quarter. Graypoint LLC boosted its holdings in shares of Agilent Technologies by 15.5% in the 4th quarter. Graypoint LLC now owns 1,782 shares of the medical research company's stock valued at $239,000 after buying an additional 239 shares in the last quarter. Czech National Bank grew its position in shares of Agilent Technologies by 4.8% in the 4th quarter. Czech National Bank now owns 62,299 shares of the medical research company's stock valued at $8,369,000 after buying an additional 2,843 shares during the last quarter. Cooper Financial Group raised its stake in Agilent Technologies by 6.8% during the 4th quarter. Cooper Financial Group now owns 1,833 shares of the medical research company's stock worth $246,000 after acquiring an additional 116 shares in the last quarter. Finally, Miracle Mile Advisors LLC acquired a new stake in Agilent Technologies during the 4th quarter worth $362,000.

Analysts Set New Price Targets

A has been the subject of a number of recent research reports. Barclays decreased their price target on shares of Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Jefferies Financial Group reduced their price objective on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a research note on Monday, April 21st. TD Cowen upped their price target on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research note on Thursday, April 10th. Wells Fargo & Company reduced their target price on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a research note on Thursday, April 17th. Finally, Robert W. Baird dropped their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a research note on Thursday, February 27th. Seven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Agilent Technologies currently has a consensus rating of "Moderate Buy" and an average price target of $143.00.

Insider Activity at Agilent Technologies

In other news, Director Daniel K. Podolsky sold 1,819 shares of the company's stock in a transaction on Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now directly owns 35,737 shares in the company, valued at $4,161,931.02. This represents a 4.84% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the transaction, the vice president now owns 21,786 shares in the company, valued at $2,657,456.28. The trade was a 8.05% decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Price Performance

NYSE A traded up $0.77 during mid-day trading on Thursday, hitting $112.29. The stock had a trading volume of 1,827,748 shares, compared to its average volume of 1,901,981. The company has a 50 day simple moving average of $110.78 and a 200 day simple moving average of $128.45. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The company has a market cap of $32.01 billion, a price-to-earnings ratio of 25.81, a P/E/G ratio of 3.25 and a beta of 1.27. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The firm had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.67 billion. Equities analysts forecast that Agilent Technologies, Inc. will post 5.54 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st were given a $0.248 dividend. The ex-dividend date of this dividend was Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.88%. Agilent Technologies's dividend payout ratio is currently 22.76%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.